CC— Chemours Co

MaterialsChemicals$2.2B mkt cap

Metric	FY2024	FY2023	FY2022	FY2021
Net sales	$5.78B-4.9%	$6.08B-11.0%	$6.83B+7.7%	$6.34B
Cost of goods sold	$4.63B-3.0%	$4.78B-8.4%	$5.21B+5.1%	$4.96B
Gross profit	$1.15B-11.6%	$1.30B-19.4%	$1.62B+17.0%	$1.38B
Selling, general, and administrative expense	$585.0M-54.5%	$1.29B+81.1%	$710.0M+19.9%	$592.0M
Research and development expense	$109.0M+0.9%	$108.0M-8.5%	$118.0M+10.3%	$107.0M
Restructuring, asset-related, and other charges	$60.0M-60.8%	$153.0M+856.3%	$16.0M+166.7%	$6.0M
Goodwill impairment charge	$56.0M	—	—	—
Total other operating expenses	$810.0M-47.6%	$1.55B+83.3%	$844.0M+19.7%	$705.0M
Equity in earnings of affiliates	$43.0M-4.4%	$45.0M-18.2%	$55.0M+27.9%	$43.0M
Interest expense, net	-$264.0M-26.9%	-$208.0M-27.6%	-$163.0M+11.9%	-$185.0M
(Loss) gain on extinguishment of debt	-$1.0M+0.0%	-$1.0M-114.3%	$7.0M+133.3%	-$21.0M
Other income, net	$8.0M-91.2%	$91.0M+30.0%	$70.0M-57.1%	$163.0M
Income (loss) before income taxes	$127.0M+139.9%	-$318.0M-142.9%	$741.0M+9.6%	$676.0M
Provision for (benefit from) income taxes	$41.0M+162.1%	-$66.0M-140.5%	$163.0M+139.7%	$68.0M
Net income (loss)	$86.0M+134.1%	-$252.0M-143.6%	$578.0M-4.9%	$608.0M
Less: Net income attributable to non-controlling interests	$1.0M+0.0%	$1.0M	—	—
Net income (loss) attributable to Chemours	$86.0M+134.0%	-$253.0M-143.8%	$578.0M-4.9%	$608.0M
Basic earnings (loss) per share of common stock	$580000.00+134.1%	-$1700000.00-145.7%	$3720000.00+0.8%	$3690000.00
Diluted earnings (loss) per share of common stock	$570000.00+133.5%	-$1700000.00-146.6%	$3650000.00+1.4%	$3600000.00

Source: SEC EDGAR XBRL. % change vs prior period shown where available.

Pro feature

Unlock 14 more years of annual history and full quarterly detail on Pro.

Upgrade to Pro →

Source: SEC EDGAR 10-K and 10-Q filings. Last 4 years annual and quarterly free, full history (up to 20 years) on Pro.